Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 29% ± 12% | |
glutamatergic neuron | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of TFB2M at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 591.02 | 1445 / 1445 | 100% | 36.79 | 183 / 183 |
ovary | 100% | 450.52 | 180 / 180 | 100% | 43.87 | 430 / 430 |
pancreas | 100% | 607.25 | 328 / 328 | 100% | 27.15 | 178 / 178 |
breast | 100% | 681.60 | 459 / 459 | 100% | 57.23 | 1117 / 1118 |
liver | 100% | 1234.00 | 226 / 226 | 100% | 47.51 | 405 / 406 |
uterus | 100% | 468.79 | 170 / 170 | 100% | 36.03 | 457 / 459 |
stomach | 99% | 633.55 | 357 / 359 | 100% | 40.25 | 285 / 286 |
intestine | 100% | 655.65 | 966 / 966 | 99% | 43.79 | 522 / 527 |
thymus | 100% | 766.72 | 653 / 653 | 99% | 30.24 | 599 / 605 |
bladder | 100% | 664.86 | 21 / 21 | 99% | 39.08 | 497 / 504 |
prostate | 100% | 565.64 | 245 / 245 | 99% | 37.01 | 495 / 502 |
skin | 100% | 913.35 | 1809 / 1809 | 97% | 49.33 | 459 / 472 |
lung | 96% | 451.26 | 554 / 578 | 100% | 46.38 | 1155 / 1155 |
kidney | 100% | 781.09 | 89 / 89 | 96% | 22.76 | 862 / 901 |
brain | 93% | 319.92 | 2461 / 2642 | 99% | 19.03 | 701 / 705 |
adrenal gland | 100% | 1720.75 | 258 / 258 | 89% | 22.41 | 205 / 230 |
adipose | 100% | 680.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.14 | 29 / 29 |
muscle | 100% | 1125.16 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 605.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.97 | 1 / 1 |
blood vessel | 98% | 380.30 | 1307 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 557.24 | 818 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 14.67 | 64 / 80 |
peripheral blood | 49% | 402.82 | 451 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006391 | Biological process | transcription initiation at mitochondrial promoter |
GO_0006390 | Biological process | mitochondrial transcription |
GO_0031167 | Biological process | rRNA methylation |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0034246 | Molecular function | mitochondrial transcription factor activity |
GO_0000179 | Molecular function | rRNA (adenine-N6,N6-)-dimethyltransferase activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | TFB2M |
Protein name | Dimethyladenosine transferase 2, mitochondrial (EC 2.1.1.-) (Hepatitis C virus NS5A-transactivated protein 5) (HCV NS5A-transactivated protein 5) (Mitochondrial 12S rRNA dimethylase 2) (Mitochondrial transcription factor B2) (h-mtTFB) (h-mtTFB2) (hTFB2M) (mtTFB2) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2) |
Synonyms | NS5ATP5 |
Description | FUNCTION: S-adenosyl-L-methionine-dependent rRNA methyltransferase which may methylate two specific adjacent adenosines in the loop of a conserved hairpin near the 3'-end of 12S mitochondrial rRNA (Probable). Component of the mitochondrial transcription initiation complex, composed at least of TFB2M, TFAM and POLRMT that is required for basal transcription of mitochondrial DNA . In this complex, TFAM recruits POLRMT to a specific promoter whereas TFB2M induces structural changes in POLRMT to enable promoter opening and trapping of the DNA non-template strand . Stimulates transcription independently of the methyltransferase activity . . |
Accessions | ENST00000366514.5 Q9H5Q4 |